BlackRock Institutional Trust’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$606K Buy
72,145
+14,613
+25% +$115K ﹤0.01% 3419
2016
Q3
$412K Buy
+57,532
New +$400K ﹤0.01% 3525
2015
Q4
Sell
-13,760
Closed -$98K 4002
2015
Q3
$98K Hold
13,760
﹤0.01% 3734
2015
Q2
$146K Buy
13,760
+3,688
+37% +$43.2K ﹤0.01% 3675
2015
Q1
$125K Buy
10,072
+4,618
+85% +$51.1K ﹤0.01% 3683
2014
Q4
$51K Hold
5,454
﹤0.01% 3767
2014
Q3
$55K Buy
5,454
+4,771
+699% +$48.5K ﹤0.01% 3712
2014
Q2
$7K Hold
683
﹤0.01% 3907
2014
Q1
$9K Hold
683
﹤0.01% 3904
2013
Q4
$8K Hold
683
﹤0.01% 3933
2013
Q3
$6K Hold
683
﹤0.01% 3918
2013
Q2
$6K Buy
+683
New +$6.11K ﹤0.01% 3932

Other funds holding ELOS

BlackRock Institutional Trust's ELOS Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Syneron Medical Ltd (ELOS) stake by 25% in Q4 2016, buying an estimated $115K and bringing the position to 72,145 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #3419.

BlackRock Institutional Trust first reported a position in ELOS in Q2 2013 and has held it in 12 quarters since. 80 funds tracked by Wall St. Rank hold ELOS as of Q4 2016.

  • BlackRock Institutional Trust held 72,145 shares of Syneron Medical Ltd worth $606K as of Q4 2016.
  • BlackRock Institutional Trust bought 14,613 Syneron Medical Ltd shares in Q4 2016, an estimated $115K.
  • Syneron Medical Ltd made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3419 holding.
  • BlackRock Institutional Trust first reported a position in Syneron Medical Ltd in Q2 2013 and has held it in 12 quarters since.
  • 80 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.